ArticleFrontiers in molecular biosciences2022

Identification of PTK2 as an adverse prognostic biomarker in breast cancer by integrated bioinformatics and experimental analyses.

Yanru Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.